Medical cannabis reform is at a critical juncture in Australia. The TGA (Therapeutic Goods Administration) recently finalised its open submission, posing 29 pivotal questions that will shape the future of access, quality, and patient care.In this episode, Chad details OnTracka's official submission in the interest of transparency. We reveal our data-driven responses to these crucial questions, covering major topics that will define the industry's direction for years to come.Join us to understand the arguments currently shaping medical cannabis policy.